The shares of Cardinal Health, Inc. (NYSE:CAH) has been pegged with a rating of Neutral by Guggenheim in its latest research note that was published on April 18th, 2019. Guggenheim wasn’t the only research firm that published a report of Cardinal Health, Inc., with other equities research analysts also giving their opinion on the stock. UBS advised investors in its research note published on January 17th, 2019, to Neutral the CAH stock while also putting a $51 price target. The stock had earned Mkt Perform rating from Leerink Partners when it published its report on November 16th, 2018. The stock was given Outperform rating by Leerink Partners in its report released on April 24th, 2018. Argus was of a view that CAH is Buy in its latest report on April 2nd, 2018. Barclays thinks that CAH is worth Equal Weight rating. This was contained in the firm’s report on March 8th, 2018 in which the stock’s price target was also moved to $74.
Amongst the analysts that rated the stock, 1 have recommended investors to sell it, 13 believe it has the potential for further growth, thus rating it as Hold while 1 advised investors to purchase the stock. The consensus currently stands at a Hold while its average price target is $49.36. The price of the stock the last time has raised by 8.87% from its Week high price while it is raised higher than its 52-Week low price. A look at the stock’s other technical shows that its 14-day RSI now stands at 48.45.
The shares of the company added by 2.03% during the trading session on Tuesday, reaching a low of $43.56 while ending the day at $44.67. During the trading session, a total of 2.16 million shares were traded which represents a 22.51% incline from the average session volume which is 2.79M shares. CAH had ended its last session trading at 43.78. Cardinal Health, Inc. currently has a market cap of $13.31B, while its P/E ratio stands at 293.88, while its P/E earnings growth sits at 0.09, with a beta of 1.29. Cardinal Health, Inc. debt-to-equity ratio currently stands at 1.46, while its quick ratio hovers at 0.50. CAH 52-week low price stands at $41.03 while its 52-week high price is $58.31.
The company in its last quarterly report recorded $1.11 earnings per share which is above the $0.93 predicted by most analysts. The Cardinal Health, Inc. generated $37,353.00 million in revenue during the last quarter, which is slightly higher than the $36,814.50 million predicted by analysts. In the second quarter last year, the firm recorded $1.59 earnings per share. Compared to the same quarter last year, the firm’s revenue was down by -43.24%. Cardinal Health, Inc. has the potential to record 0.15 EPS for the current fiscal year, according to equities analysts.
Investment analysts at Nomura published a research note on March 27th, 2019 where it informed investors and clients that Two Harbors Investment Corp. (NYSE:TWO) is now rated as Neutral. UBS also rated TWO as Initiated on January 17th, 2019, with its price target of $60 suggesting that TWO could surge by 8.33% from its current share price. Even though the stock has been trading at $13.32/share, analysts expect it to surge higher by 0.00% to reach $14.53/share. It started the day trading at $13.41 and traded between $13.28 and $13.32 throughout the trading session.
A look at its technical shows that TWO’s 50-day SMA is 12.94 while its 200-day SMA stands at 13.62. At the moment, only of Two Harbors Investment Corp. shares were sold short. The company’s average trading volume currently stands at 2.98M shares, which means that the short-interest ratio is just 3.16 days. Over the past seven days, the company moved, with its shift of 0.83%. Looking further, the stock has raised 0.45% over the past 90 days while it lost -4.79% over the last six months.
The change in the stock’s fortunes has led to several institutional investors altering their holdings of the stock. The Vanguard Group Inc bought more TWO shares, increasing its portfolio by +10.99% during the last quarter. This move now sees The Vanguard Group Inc purchasing 2,505,204 shares in the last quarter, thus it now holds 25,309,965 shares of TWO, with a total valuation of $340,672,129. BlackRock Fund Advisors meanwhile sold more TWO shares in the recently filed quarter, changing its stake to $192,784,673 worth of shares.
Similarly, Nan Shan Life Insurance Co Ltd decreased its Two Harbors Investment Corp. shares by 0.00% during the recently filed quarter. After selling 0 shares in the last quarter, the firm now controls 5,652,380 shares of Two Harbors Investment Corp. which are valued at $76,081,035. In the same vein, Delphi Financial Group Inc increased its Two Harbors Investment Corp. shares by during the most recent reported quarter. The firm bought 411,500 shares during the quarter which increased its stakes to 4,318,685 shares and is now valued at $58,129,500. Following these latest developments, around 0.60% of Two Harbors Investment Corp. stocks are owned by institutional investors and hedge funds.